Work

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

Year: 2021
Type: article
Abstract: AIMS: The aim of this study was to develop, validate, and illustrate an updated prediction model (SCORE2) to estimate 10-year fatal and non-fatal cardiovascular disease (CVD) risk in individuals without previous CVD or diabetes aged 40-69 years in Europe. METHODS AND RESULTS: We derived risk prediction models using individual-participant data from 45 cohorts in 13 countries (677 684 individuals, 30 121 CVD events). We used sex-specific and competing risk-adjusted models, including age, smoking status, systolic blood pressure, and total- and HDL-cholesterol. We defined four risk regions in Europe according to country-specific CVD mortality, recalibrating models to each region using expected incidences and risk factor distributions. Region-specific incidence was estimated using CVD mortality and incidence data on 10 776 466 individuals. For external validation, we analysed data from 25 additional cohorts in 15 European countries (1 133 181 individuals, 43 492 CVD events). After applying the derived risk prediction models to external validation cohorts, C-indices ranged from 0.67 (0.65-0.68) to 0.81 (0.76-0.86). Predicted CVD risk varied several-fold across European regions. For example, the estimated 10-year CVD risk for a 50-year-old smoker, with a systolic blood pressure of 140 mmHg, total cholesterol of 5.5 mmol/L, and HDL-cholesterol of 1.3 mmol/L, ranged from 5.9% for men in low-risk countries to 14.0% for men in very high-risk countries, and from 4.2% for women in low-risk countries to 13.7% for women in very high-risk countries. CONCLUSION: SCORE2-a new algorithm derived, calibrated, and validated to predict 10-year risk of first-onset CVD in European populations-enhances the identification of individuals at higher risk of developing CVD across Europe.
Authors: Steven Hageman, Lisa Pennells, Francisco Ojeda, Stephen Kaptoge, Kari Kuulasmaa, Tamar de Vries, Zhe Xu, Frank Kee, Ryan Chung, Angela Wood, John William McEvoy, Giovanni Veronesi, Thomas Bolton, Stephan Achenbach, Krasimira Aleksandrova, Pilar Amiano, Donostia-San Sebastian, Philippe Amouyel, Jonas Andersson, Stephan J L Bakker, Rui Bebiano Da Providencia Costa, Joline W J Beulens, Michael Blaha, Martin Bobak, Jolanda M A Boer, Catalina Bonet, Fabrice Bonnet, Marie-Christine Boutron-Ruault, Tonje Braaten, Hermann Brenner, Fabian Brunner, Eric J Brunner, Mattias Brunström, Julie Buring, Adam S Butterworth, Nadezda Capkova, Giancarlo Cesana, Christina Chrysohoou, Sandra Colorado-Yohar, Nancy R Cook, Cyrus Cooper, Christina C Dahm, Karina Davidson, Elaine Dennison, Augusto Di Castelnuovo, Chiara Donfrancesco, Marcus Dörr, Agnieszka Doryńska, Mats Eliasson, Gunnar Engström, Pietro Ferrari, Marco Ferrario, Ian Ford, Michael Fu, Ron T Gansevoort, Simona Giampaoli, Richard F Gillum, Agustin Gómez de la Cámara, Guido Grassi, Per-Olof Hansson, Radu Huculeci, Kristian Hveem, Licia Iacoviello, M Kamran Ikram, Torben Jørgensen, Bijoy Joseph, Pekka Jousilahti, J Wouter Jukema, Rudolf Kaaks, Verena Katzke, Maryam Kavousi, Stefan Kiechl, Jens Klotsche, Wolfgang König, Richard A Kronmal, Ruzena Kubinova, Anna Kucharska-Newton, Kristi Läll, Nils Lehmann, David Leistner, Allan Linneberg, David Lora Pablos, Thiess Lorenz, Wentian Lu, Dalia Luksiene, Magnus Lyngbakken, Christina Magnussen, Sofia Malyutina, Alejandro Marín Ibañez, Giovanna Masala, Ellisiv B Mathiesen, Kuni Matsushita, Tom W Meade, Olle Melander, Haakon E Meyer, Karel G M Moons, Conchi Moreno-Iribas, David Muller, Thomas Münzel, Yury Nikitin, Børge G Nordestgaard, Torbjørn Omland, Charlotte Onland, Kim Overvad, Chris Packard, Andrzej Pająk, Luigi Palmieri, Demosthenes Panagiotakos, Salvatore Panico, Aurora Perez-Cornago, Annette Peters, Arto Pietilä, , Hynek Pikhart, Bruce M Psaty, Fosca Quarti-Trevano, J Ramón Quirós Garcia, Elio Riboli, Paul M Ridker, Beatriz Rodriguez, Miguel Rodriguez-Barranco, Annika Rosengren, Ronan Roussel, Carlotta Sacerdote, Susana Sans, Naveed Sattar, Catarina Schiborn, Börge Schmidt, Ben Schöttker, Matthias Schulze, Joseph E Schwartz, Randi Marie Selmer, Steven Shea, Martin J Shipley, Sabina Sieri, Stefan Söderberg, Reecha Sofat, Abdonas Tamosiunas, Barbara Thorand, Taavi Tillmann, Anne Tjønneland, Tammy Y N Tong, Antonia Trichopoulou, Rosario Tumino, Hugh Tunstall-Pedoe, Anne Tybjaerg-Hansen, Joanna Tzoulaki, Amber van der Heijden, Yvonne T van der Schouw, W M Monique Verschuren, Henry Völzke, Christoph Waldeyer, Nicholas J Wareham, Elisabete Weiderpass, Franz Weidinger, Philipp Wild, Johann Willeit, Peter Willeit, Tom Wilsgaard, Mark Woodward, Tanja Zeller, Dudan Zhang, Bin Zhou, Paul Dendale, Brian A Ference, Martin Halle, Adam Timmis, Panos Vardas, John Danesh, Ian Graham, Veikko Salomaa, Frank Visseren, Dirk De Bacquer, Stefan Blankenberg, Jannick Dorresteijn, Emanuele Di Angelantonio
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,592
Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, GlaxoSmithKline, Sanofi, Brigham and Women's Hospital, Harvard University, Universitetet i Tromsø, Foundation for Cardiovascular Research, Aarhus Universitet, University of Washington, Johns Hopkins University, Deutsches Krebsforschungszentrum, University of Dundee, Uniwersytet Jagielloński Collegium Medicum, Norges Teknisk-Naturvitenskapelige Universitet, Queen Mary University of London, National University of Ireland, Wellcome Trust, Deutsches Zentrum für Herz-Kreislaufforschung, European Association of Social Psychology, Scottish Government, Alan Turing Institute, Amarin Corporation, Kowa Company, Northwell Health, Cancer Research UK, National Institute for Health and Care Research, British Heart Foundation, Department of Health and Social Care, University of Cambridge, University of Southampton, Imperial College London, University College London, University of Oxford, European Commission, University of Glasgow, European Society of Cardiology, Public Health Agency, University of Galway, Trinity College Dublin, Universität Heidelberg, Institut National de la Santé et de la Recherche Médicale, Universiteit Leiden, Rijksuniversiteit Groningen, University of New South Wales, Universiteit Utrecht, Vrije Universiteit Amsterdam, Eesti Teadusagentuur, Bundesministerium für Bildung und Forschung, Austrian Science Fund, Aalborg Universitet, Cancerfonden, Gentofte Hospital, Università degli Studi di Milano-Bicocca, Lunds Universitet, Queen's University, Universitair Medisch Centrum Utrecht, Ligue Contre le Cancer, Novo Nordisk, Vetenskapsrådet, Universiteit Gent, Associazione Italiana per la Ricerca sul Cancro, Leids Universitair Medisch Centrum, Rigshospitalet, National and Kapodistrian University of Athens, Universidad de Antioquia, Universitetet i Oslo, Università degli Studi dell'Insubria, Sydäntutkimussäätiö, Technische Universität München, Sahlgrenska Universitetssjukhuset, Göteborgs Universitet, Deutsche Krebshilfe, Aalborg Universitetshospital, Tartu Ülikool, Institut Gustave-Roussy, Faculty of Health and Medical Sciences, University of Western Australia, Harokopio University, Universiteit Hasselt, Siemens Healthineers, Servier, Akershus Universitetssykehus, Lietuvos Sveikatos Mokslų Universitetas, Universität Greifswald, George Institute for Global Health, Red de Investigación en Servicios de Salud en Enfermedades Crónicas, National Institutes of Health, Novartis Pharma, Abbott Diagnostics, Chief Scientist Office, Scottish Government Health and Social Care Directorate, Bayer Vital, Feinstein Institutes for Medical Research, Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, World Cancer Research Fund, Instituto de Salud Carlos III, Sahlgrenska Akademin, Det Sundhedsvidenskabelige Fakultet, Københavns Universitet, Rijksinstituut voor Volksgezondheid en Milieu, European Regional Development Fund, Health and Social Care Research and Development Division, NIHR Imperial Biomedical Research Centre, Netherlands Heart Institute, School of Public Health, Imperial College London, NIHR Cambridge Biomedical Research Centre, Norwegian Institute of Public Health, National Institute on Aging, National Heart, Lung, and Blood Institute, Mailman School of Public Health, Columbia University, FP7 Ideas: European Research Council, Health Data Research UK
Awards: G1077033501, Personalised Medicine by Predictive Modeling in Stroke for better Quality of Life, G1121450242, G1141147264, G1192877484, G139696651, G1478484880, DIGITAL, RISK-BASED SCREENING FOR ATRIAL FIBRILLATION IN THE EUROPEAN COMMUNITY, NIHR Senior Investigator Award, Determinants of cardiovascular diseases in Eastern Europe: a multi-centre cohort study., G1888088267, G1953887145, G2027148636, G2165920734, Biomarker for Cardiovascular Risk Assessment in Europe, Large-scale integrative genomic studies of high-dimensional traits in cardiovascular diseases (renewal), G2479166409, G2626190046, G2975900969, G299057155, G3141415527, Research Excellence (round 3), G3328679326, The Whitehall II study: A Core Resource for Ageing Research, G3584577881, G370598735, G375319704, G3863117035, G3986547339, Vascular Risk and Functional Decline in Old Age: From Discovery to Translation, Role of Rare and Common Genetic Variants in Adverse Drug Reactions, G4157907644, G4213141252, Prevention of dementia by targeting risk factors, G434337789, An EU-Canada joint infrastructure for next-generation multi-Study Heart research, The Centre of Excellence for Public Health (NI) - Phase II (CoEfPHNI/II), Health disparities and aging in societies in transition, Taking the long view: Identification of plasma protein biomarkers for dementia risk, Health of vegetarians, G4584873075, G459595259, G4680340021, European Network for Genetic and Genomic Epidemiology, G4844208673, Development and application of genetic risk prediction algorithms for personalised healthcare in the era of large-scale genomics, G5176409192, G5396620181, G5469207022, G5484725842, G5897142711, G5976883868, G6058803565, Enhancing cardiovascular disease risk prediction through using longitudinal measures of risk factors in clustered data, G6077662935, G6091493096, G6151225597, NIHR Senior Investigator Award, G616188461, G6329461015, G6364753491, G6423345783, G6492843860, G6539078855, EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations, the Center for Genomics, Evolution and Medicine, Genetic and epidemiological predictors for all-cause and cause-specific mortality in the Estonian population., The BHF-Turing Cardiovascular Data Science Awards (First Call): Using machine learning for personalised CVD risk management (joint funding with The Alan Turing Institute), Predicting comorbid cardiovascular disease in individuals with mental disorder by decoding disease mechanisms, G7038536643, G7207596054, G7426181285, Interplay of genetic, nutrient and lifestyle factors on incidence of coronary disease: EPIC-Heart, Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application. (renewal) (Joint funding with MRC), Utilising special human populations to quantify the impact of rare DNA sequence variants in human health, G7646326732, G7677770324, Consortium on Health and Ageing: Network of Cohorts in Europe and the United States, G7926827615, G8164184896, G8645943772, G8978728421, Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application, G93929969
OpenAlex ID: W3166015112
FWCI: 185.5
Cites: 46
Cited by: 2,313
Related to: 10